Clinical Trial Update: Treatment of TK2 Deficiency With Thymidine and Deoxycytidine [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial entry reports a Phase 1/2 study evaluating thymidine and deoxycytidine for TK2 deficiency. The trial is currently active and not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mitochondrial Dna Depletion Syndrome Myopathic Type
• Thymidine Kinase Deficiency

Drugs mentioned

• Deoxycytidine (2'-deoxycytidine)
• Thymidine (2'-deoxythymidine)

Snippet

Sponsor: Columbia University | Conditions: Mitochondrial DNA Depletion Syndrome 2 Myopathic Type, Thymidine Kinase 2 Deficiency | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING